| MeSH term | MeSH ID | Detail |
|---|---|---|
| Cystadenocarcinoma, Mucinous | D018282 | 1 associated lipids |
| Carcinoma, Ductal, Breast | D018270 | 19 associated lipids |
| Carcinoma, Papillary, Follicular | D018265 | 1 associated lipids |
| Adenocarcinoma, Follicular | D018263 | 3 associated lipids |
| Carcinoma, Embryonal | D018236 | 8 associated lipids |
| Rhabdomyosarcoma, Embryonal | D018233 | 1 associated lipids |
| Rhabdomyosarcoma, Alveolar | D018232 | 2 associated lipids |
| Fibromatosis, Aggressive | D018222 | 2 associated lipids |
| Lymphoma, Large-Cell, Anaplastic | D017728 | 3 associated lipids |
| Hypereosinophilic Syndrome | D017681 | 3 associated lipids |
trichostatin A
Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.
Cross Reference
Introduction
To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with trichostatin A?
trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with trichostatin A
PubChem Associated disorders and diseases
What pathways are associated with trichostatin A
Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with trichostatin A?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with trichostatin A?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with trichostatin A?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with trichostatin A?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with trichostatin A?
Mouse Model
Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).
Xenograft Model
Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).
Cancer Model
Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with trichostatin A
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Smetana K et al. | Effect of histone deacetylase inhibitors on the cell nucleus and nucleolus of leukemic myeloblasts in vitro - a cytochemical study. | 2007 | Acta Histochem. | pmid:17559910 |
| Ye J et al. | De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists. | 2007 | J. Virol. | pmid:17596302 |
| Tuncel M et al. | The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake. | 2007 | Cancer Biother. Radiopharm. | pmid:17600477 |
| Kaneko M et al. | Mechanism for the differentiation of EoL-1 cells into eosinophils by histone deacetylase inhibitors. | 2007 | Int. Arch. Allergy Immunol. | pmid:17541273 |
| Schwechter BR et al. | Histone deacetylase inhibition-mediated differentiation of RGC-5 cells and interaction with survival. | 2007 | Invest. Ophthalmol. Vis. Sci. | pmid:17525221 |
| Turaga RV et al. | Werner syndrome protein prevents DNA breaks upon chromatin structure alteration. | 2007 | Aging Cell | pmid:17521388 |
| Wang LG et al. | Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer. | 2007 | Mol. Carcinog. | pmid:16921492 |
| Uchida H et al. | Histone deacetylase inhibitors stimulate cell migration in human endometrial adenocarcinoma cells through up-regulation of glycodelin. | 2007 | Endocrinology | pmid:17068141 |
| Vikhanskaya F et al. | Cancer-derived p53 mutants suppress p53-target gene expression--potential mechanism for gain of function of mutant p53. | 2007 | Nucleic Acids Res. | pmid:17344317 |
| Krennhrubec K et al. | Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors. | 2007 | Bioorg. Med. Chem. Lett. | pmid:17346959 |
| Vincent A et al. | Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. | 2007 | Oncogene | pmid:17471237 |
| Zhang C et al. | Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. | 2007 | J. Pathol. | pmid:17471463 |
| Gensert JM et al. | CD81, a cell cycle regulator, is a novel target for histone deacetylase inhibition in glioma cells. | 2007 | Neurobiol. Dis. | pmid:17481908 |
| Mayo C et al. | In vitro differentiation of HT-29 M6 mucus-secreting colon cancer cells involves a trychostatin A and p27(KIP1)-inducible transcriptional program of gene expression. | 2007 | J. Cell. Physiol. | pmid:17311291 |
| Jung EJ et al. | Lytic induction and apoptosis of Epstein-Barr virus-associated gastric cancer cell line with epigenetic modifiers and ganciclovir. | 2007 | Cancer Lett. | pmid:16647201 |
| Avila AM et al. | Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. | 2007 | J. Clin. Invest. | pmid:17318264 |
| Kang JH et al. | Inhibition of trichostatin A-induced antiangiogenesis by small-interfering RNA for thrombospondin-1. | 2007 | Exp. Mol. Med. | pmid:17603295 |
| Subramanian C et al. | CREB-binding protein is a mediator of neuroblastoma cell death induced by the histone deacetylase inhibitor trichostatin A. | 2007 | Neoplasia | pmid:17603632 |
| Chen B and Cepko CL | Requirement of histone deacetylase activity for the expression of critical photoreceptor genes. | 2007 | BMC Dev. Biol. | pmid:17603891 |
| Glenisson W et al. | Histone deacetylase 4 is required for TGFbeta1-induced myofibroblastic differentiation. | 2007 | Biochim. Biophys. Acta | pmid:17610967 |
| Zhang X et al. | Suppression of DPYD expression in RKO cells via DNA methylation in the regulatory region of the DPYD promoter: a potentially important epigenetic mechanism regulating DPYD expression. | 2007 | Biochem. Cell Biol. | pmid:17612628 |
| Shi J et al. | Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis. | 2007 | Cancer Res. | pmid:17616702 |
| Perales M and Más P | A functional link between rhythmic changes in chromatin structure and the Arabidopsis biological clock. | 2007 | Plant Cell | pmid:17616736 |
| Zhao Y et al. | Roles of histone acetylation modification in basal and inducible expression of hsp26 gene in D. melanogaster. | 2007 | Mol. Cell. Biochem. | pmid:17619947 |
| El-Khoury V et al. | The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model. | 2007 | Br. J. Cancer | pmid:17667922 |
| Rouhi A et al. | Plasticity of Ly49g expression is due to epigenetics. | 2007 | Mol. Immunol. | pmid:16750269 |
| Sekhavat A et al. | Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate. | 2007 | Biochem. Cell Biol. | pmid:18059533 |
| Seo H et al. | Modulation of immunoglobulin gene conversion in chicken DT40 by enhancing histone acetylation, and its application to antibody engineering. | 2007 | Biotechnol. Genet. Eng. Rev. | pmid:18059633 |
| Mazières J et al. | Epigenetic regulation of RhoB loss of expression in lung cancer. | 2007 | BMC Cancer | pmid:18047684 |
| Shimazu T et al. | [Biological diversity of protein lysine acetylation which has been revealed by small molecule inhibitors]. | 2007 | Tanpakushitsu Kakusan Koso | pmid:18051411 |
| Yoshida M | [Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A]. | 2007 | Tanpakushitsu Kakusan Koso | pmid:18051427 |
| Cras A et al. | Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells. | 2007 | Oncogene | pmid:17213810 |
| Rao J et al. | Trichostatin-A induces differential changes in histone protein dynamics and expression in HeLa cells. | 2007 | Biochem. Biophys. Res. Commun. | pmid:17869223 |
| Karagiannis TC et al. | Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments. | 2007 | Oncogene | pmid:17213813 |
| Ohoka N et al. | Critical and functional regulation of CHOP (C/EBP homologous protein) through the N-terminal portion. | 2007 | J. Biol. Chem. | pmid:17872950 |
| Elaut G et al. | A metabolic screening study of trichostatin A (TSA) and TSA-like histone deacetylase inhibitors in rat and human primary hepatocyte cultures. | 2007 | J. Pharmacol. Exp. Ther. | pmid:17218485 |
| Kenneth NS et al. | TRRAP and GCN5 are used by c-Myc to activate RNA polymerase III transcription. | 2007 | Proc. Natl. Acad. Sci. U.S.A. | pmid:17848523 |
| Ting CH et al. | Stat5 constitutive activation rescues defects in spinal muscular atrophy. | 2007 | Hum. Mol. Genet. | pmid:17220171 |
| Lattal KM et al. | Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction. | 2007 | Behav. Neurosci. | pmid:17907845 |
| Yang H et al. | Dexamethasone-induced protein degradation in cultured myotubes is p300/HAT dependent. | 2007 | Am. J. Physiol. Regul. Integr. Comp. Physiol. | pmid:16973938 |
| Zhang Y et al. | An epigenetic modifier results in improved in vitro blastocyst production after somatic cell nuclear transfer. | 2007 | Cloning Stem Cells | pmid:17907946 |
| Noro R et al. | PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors. | 2007 | Int. J. Oncol. | pmid:17912443 |
| Kim EJ et al. | Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. | 2007 | Mol. Cell | pmid:17964266 |
| Shen L et al. | Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. | 2007 | PLoS Genet. | pmid:17967063 |
| Stiehl DP et al. | Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation. | 2007 | Cancer Res. | pmid:17332356 |
| Jung J and Bonini N | CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease. | 2007 | Science | pmid:17332375 |
| Jaffe RC et al. | Histone deacetylase inhibition and progesterone act synergistically to stimulate baboon glycodelin gene expression. | 2007 | J. Mol. Endocrinol. | pmid:17339403 |
| Alimirah F et al. | IFI16 in human prostate cancer. | 2007 | Mol. Cancer Res. | pmid:17339605 |
| Wu Y and Guo SW | Suppression of IL-1beta-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells. | 2007 | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:17296257 |
| Shivashimpi GM et al. | Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework. | 2007 | Bioorg. Med. Chem. | pmid:17881232 |
| Kwon HS et al. | Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression. | 2006 Mar-Apr | Biochim. Biophys. Acta | pmid:16757381 |
| Pazmany T and Tomasi TB | The major histocompatibility complex class II transactivator is differentially regulated by interferon-gamma and transforming growth factor-beta in microglial cells. | 2006 | J. Neuroimmunol. | pmid:16360884 |
| Lee KY et al. | NF-kappaB and activator protein 1 response elements and the role of histone modifications in IL-1beta-induced TGF-beta1 gene transcription. | 2006 | J. Immunol. | pmid:16365456 |
| Hansen KR et al. | Evolutionary-conserved telomere-linked helicase genes of fission yeast are repressed by silencing factors, RNAi components and the telomere-binding protein Taz1. | 2006 | Nucleic Acids Res. | pmid:16407326 |
| Dowdy SC et al. | Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells. | 2006 | Mol. Cancer Ther. | pmid:17121923 |
| Fischer S et al. | Histone acetylation dependent allelic expression imbalance of BAPX1 in patients with the oculo-auriculo-vertebral spectrum. | 2006 | Hum. Mol. Genet. | pmid:16407370 |
| Saunders LR and Verdin E | Ornithine decarboxylase activity in tumor cell lines correlates with sensitivity to cell death induced by histone deacetylase inhibitors. | 2006 | Mol. Cancer Ther. | pmid:17121924 |
| Bieler A et al. | Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520. | 2006 | Hum. Gene Ther. | pmid:16409125 |
| Lo PK et al. | Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer. | 2006 | Cancer Biol. Ther. | pmid:16410723 |
| ChuÄkin IA et al. | [Anti-proliferative effect of histone deacetylase inhibitors on murine embryonic stem cells]. | 2006 | Tsitologiia | pmid:17147260 |
| Zou B et al. | Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers. | 2006 | Gastroenterology | pmid:17087954 |
| Anderson I | Deacetylase inhibitors aid recovery in muscular dystrophy. | 2006 | Lancet Neurol | pmid:17089447 |
| Magnaghi-Jaulin L and Jaulin C | Histone deacetylase activity is necessary for chromosome condensation during meiotic maturation in Xenopus laevis. | 2006 | Chromosome Res. | pmid:16628502 |
| Pavan Kumar P et al. | Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. | 2006 | Mol. Cell | pmid:16630892 |
| Vinken M et al. | Trichostatin a enhances gap junctional intercellular communication in primary cultures of adult rat hepatocytes. | 2006 | Toxicol. Sci. | pmid:16531468 |
| Gastaldi T et al. | Plakoglobin is differentially expressed in alveolar and embryonal rhabdomyosarcoma and is regulated by DNA methylation and histone acetylation. | 2006 | Carcinogenesis | pmid:16537559 |
| Tada Y et al. | Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. | 2006 | J. Natl. Cancer Inst. | pmid:16537832 |
| Bishop CL et al. | Role for centromeric heterochromatin and PML nuclear bodies in the cellular response to foreign DNA. | 2006 | Mol. Cell. Biol. | pmid:16537904 |
| Gagnon JF et al. | Irinotecan inactivation is modulated by epigenetic silencing of UGT1A1 in colon cancer. | 2006 | Clin. Cancer Res. | pmid:16551870 |
| Rebbaa A et al. | The role of histone acetylation versus DNA damage in drug-induced senescence and apoptosis. | 2006 | Cell Death Differ. | pmid:16557274 |
| Nygård M et al. | Thyroid hormone-mediated negative transcriptional regulation of Necdin expression. | 2006 | J. Mol. Endocrinol. | pmid:16720720 |
| Armstrong K et al. | NF-kappaB activation upregulates fibroblast growth factor 8 expression in prostate cancer cells. | 2006 | Prostate | pmid:16683270 |
| Wischnewski F et al. | Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells. | 2006 | Mol. Cancer Res. | pmid:16687489 |
| Yamada N et al. | MUC2 expression is regulated by histone H3 modification and DNA methylation in pancreatic cancer. | 2006 | Int. J. Cancer | pmid:16721789 |
| Kim Y et al. | Effects of acetylation, polymerase phosphorylation, and DNA unwinding in glucocorticoid receptor transactivation. | 2006 | J. Steroid Biochem. Mol. Biol. | pmid:16723222 |
| Santander VS et al. | Tubulin must be acetylated in order to form a complex with membrane Na(+),K (+)-ATPase and to inhibit its enzyme activity. | 2006 | Mol. Cell. Biochem. | pmid:16733802 |
| Kong Y et al. | Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. | 2006 | Circulation | pmid:16735673 |
| Dannenberg LO et al. | Differential regulation of the alcohol dehydrogenase 1B (ADH1B) and ADH1C genes by DNA methylation and histone deacetylation. | 2006 | Alcohol. Clin. Exp. Res. | pmid:16737450 |
| Stewart MD et al. | Dynamic regulation of histone modifications in Xenopus oocytes through histone exchange. | 2006 | Mol. Cell. Biol. | pmid:16943430 |
| Hirsch CL et al. | Src family kinase members have a common response to histone deacetylase inhibitors in human colon cancer cells. | 2006 | Int. J. Cancer | pmid:16094635 |
| Scott SA et al. | 5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation. | 2006 | Leuk. Res. | pmid:16043219 |
| Hofmann A et al. | Epigenetic regulation of lentiviral transgene vectors in a large animal model. | 2006 | Mol. Ther. | pmid:16140581 |
| Mai A et al. | Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors. | 2006 | J. Med. Chem. | pmid:17004718 |
| Yao J et al. | NF-kappaB signaling pathway is involved in growth inhibition, G2/M arrest and apoptosis induced by Trichostatin A in human tongue carcinoma cells. | 2006 | Pharmacol. Res. | pmid:17005413 |
| Jung JW et al. | Effects of the histone deacetylases inhibitors sodium butyrate and trichostatin A on the inhibition of gap junctional intercellular communication by H2O2- and 12-O-tetradecanoylphorbol-13-acetate in rat liver epithelial cells. | 2006 | Cancer Lett. | pmid:16337085 |
| Okamoto H et al. | Trichostatin A, an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21(WAF1). | 2006 | J. Atheroscler. Thromb. | pmid:16908950 |
| Claus R et al. | Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression. | 2006 | J. Leukoc. Biol. | pmid:17000900 |
| Kogai T et al. | Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. | 2006 | Endocr. Relat. Cancer | pmid:16954431 |
| Tyson-Capper AJ et al. | Characterization of cellular retinoid-binding proteins in human myometrium during pregnancy. | 2006 | Mol. Hum. Reprod. | pmid:16959971 |
| Chen J et al. | Trichostatin A improves the anticancer activity of low concentrations of curcumin in human leukemia cells. | 2006 | Pharmazie | pmid:16964716 |
| Kim MY et al. | A repressor complex, AP4 transcription factor and geminin, negatively regulates expression of target genes in nonneuronal cells. | 2006 | Proc. Natl. Acad. Sci. U.S.A. | pmid:16924111 |
| Mühlethaler-Mottet A et al. | Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio. | 2006 | BMC Cancer | pmid:16930472 |
| Seo H et al. | An ex vivo method for rapid generation of monoclonal antibodies (ADLib system). | 2006 | Nat Protoc | pmid:17406441 |
| Banchio C et al. | Role of histone deacetylase in the expression of CTP:phosphocholine cytidylyltransferase alpha. | 2006 | J. Biol. Chem. | pmid:16484221 |
| Weaver IC et al. | Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. | 2006 | Proc. Natl. Acad. Sci. U.S.A. | pmid:16484373 |
| Fandy TE and Srivastava RK | Trichostatin A sensitizes TRAIL-resistant myeloma cells by downregulation of the antiapoptotic Bcl-2 proteins. | 2006 | Cancer Chemother. Pharmacol. | pmid:16435155 |
| Deng G et al. | Regional hypermethylation and global hypomethylation are associated with altered chromatin conformation and histone acetylation in colorectal cancer. | 2006 | Int. J. Cancer | pmid:16425274 |
| Huang L et al. | Activation of ATP-sensitive K channels protects hippocampal CA1 neurons from hypoxia by suppressing p53 expression. | 2006 | Neurosci. Lett. | pmid:16426753 |
| Kim IA et al. | Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: class differences and the potential influence of p53. | 2006 | Clin. Cancer Res. | pmid:16467109 |
| Osborn NK et al. | Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasia. | 2006 | Clin. Gastroenterol. Hepatol. | pmid:16469682 |